Reynolds Mark 4

What Happened Mark Reynolds, Chief Financial Officer of GeoVax Labs, Inc. (GOVX), was granted a derivative award for 17,600 shares on 2026-06-17. The Form 4 lists the acquisition price as $0.00 and treats the grant as a derivative security (not an open-market purchase). This is a compensation award rather than a sale or outright cash purchase.

Key Details

• Transaction date: 2026-06-17; Form 4 filed: 2026-06-22 (appears to be filed after the typical two-business-day window — filing timeliness flagged as late).
• Reported amount: 17,600 shares (derivative award); reported price: $0.00.
• Vesting/exercisability: Becomes exercisable in three equal annual installments on the first three anniversaries of the grant (per footnote).
• Shares owned after transaction: Not specified in this filing.
• Transaction code: A = Grant/Award (derivative).

Context This was a grant of derivative securities (commonly stock options or restricted stock units) that will vest over three years; it does not represent an immediate market purchase or sale. Such awards are routine executive compensation and do not by themselves indicate the insider is buying or selling shares in the open market. The late filing may be relevant for compliance tracking but does not change the nature of the award.